SG Americas Securities LLC Increases Stock Holdings in Inspire Medical Systems, Inc. (NYSE:INSP)

SG Americas Securities LLC boosted its stake in Inspire Medical Systems, Inc. (NYSE:INSPFree Report) by 33.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 3,534 shares of the company’s stock after acquiring an additional 892 shares during the quarter. SG Americas Securities LLC’s holdings in Inspire Medical Systems were worth $655,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Nisa Investment Advisors LLC boosted its position in Inspire Medical Systems by 37.3% in the 4th quarter. Nisa Investment Advisors LLC now owns 368 shares of the company’s stock valued at $68,000 after buying an additional 100 shares during the last quarter. Merit Financial Group LLC acquired a new position in shares of Inspire Medical Systems in the fourth quarter worth about $313,000. Pallas Capital Advisors LLC boosted its holdings in Inspire Medical Systems by 6.1% in the fourth quarter. Pallas Capital Advisors LLC now owns 4,037 shares of the company’s stock valued at $748,000 after purchasing an additional 233 shares during the last quarter. Wealth Enhancement Advisory Services LLC grew its stake in Inspire Medical Systems by 1.0% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 7,879 shares of the company’s stock valued at $1,461,000 after purchasing an additional 79 shares in the last quarter. Finally, Diversified Trust Co grew its stake in Inspire Medical Systems by 3.8% during the 4th quarter. Diversified Trust Co now owns 4,686 shares of the company’s stock valued at $869,000 after purchasing an additional 173 shares in the last quarter. Hedge funds and other institutional investors own 94.91% of the company’s stock.

Inspire Medical Systems Stock Performance

NYSE INSP opened at $194.38 on Friday. The firm has a market capitalization of $5.83 billion, a PE ratio of 181.67 and a beta of 1.32. Inspire Medical Systems, Inc. has a one year low of $123.00 and a one year high of $257.40. The company has a 50-day simple moving average of $189.95 and a 200-day simple moving average of $187.94.

Inspire Medical Systems (NYSE:INSPGet Free Report) last issued its earnings results on Monday, November 4th. The company reported $0.60 EPS for the quarter, beating analysts’ consensus estimates of $0.06 by $0.54. The company had revenue of $203.20 million during the quarter, compared to the consensus estimate of $197.59 million. Inspire Medical Systems had a return on equity of 5.30% and a net margin of 4.37%. Inspire Medical Systems’s quarterly revenue was up 32.6% compared to the same quarter last year. During the same period in the previous year, the firm posted ($0.29) earnings per share. Equities analysts forecast that Inspire Medical Systems, Inc. will post 1.35 earnings per share for the current year.

Analyst Ratings Changes

A number of brokerages have issued reports on INSP. Wells Fargo & Company upped their target price on Inspire Medical Systems from $187.00 to $198.00 and gave the company an “equal weight” rating in a research report on Tuesday, November 5th. Piper Sandler reiterated an “overweight” rating and set a $260.00 price objective (up from $255.00) on shares of Inspire Medical Systems in a research note on Tuesday, November 5th. KeyCorp reissued an “overweight” rating and set a $234.00 price objective (down from $236.00) on shares of Inspire Medical Systems in a report on Friday, January 24th. Robert W. Baird upped their target price on shares of Inspire Medical Systems from $240.00 to $252.00 and gave the company an “outperform” rating in a research note on Tuesday, November 5th. Finally, Bank of America upgraded Inspire Medical Systems from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $220.00 to $255.00 in a research note on Wednesday, November 20th. Three research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to data from MarketBeat, Inspire Medical Systems presently has an average rating of “Moderate Buy” and a consensus price target of $231.45.

Get Our Latest Research Report on INSP

Inspire Medical Systems Profile

(Free Report)

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.

Further Reading

Want to see what other hedge funds are holding INSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Inspire Medical Systems, Inc. (NYSE:INSPFree Report).

Institutional Ownership by Quarter for Inspire Medical Systems (NYSE:INSP)

Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.